N-Acetyltransferase-1 gene polymorphisms and correlation between genotype and its activity in a central Chinese Han population

Clinica Chimica Acta

Volumn 371, Issue 1-2, 2006, Pages 85-91

  Zhangwei, Xu ^a,b   Jianming, Xu ^b   Qiao, Mei ^b   Xinhua, Xu ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Medical University   (China)

Author keywords

Chinese; Genetic polymorphism; Genotype; N Acetyltransferases 1; Phenotype

Indexed keywords

N ACETYLTRANSFERASE 1; PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CALCULATION; CHINESE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; ENZYME ACTIVITY; ENZYME KINETICS; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOSITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOZYGOSITY; HUMAN; LEUKOCYTE; MALE; MICHAELIS CONSTANT; NORMAL HUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ARYLAMINE N-ACETYLTRANSFERASE; BASE SEQUENCE; CHINA; DEMOGRAPHY; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; ISOENZYMES; LEUKOCYTES; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 33746800293     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.02.025     Document Type: Article

References (28)

1. Hopwood J.J., and Elliott H. The diagnosis of the Sanfilippo C syndrome, using monosaccharide and oligosaccharide substrates to assay acetyl-CoA: 2-amino-2-deoxy-alpha-glucoside N-acetyltransferase activity. Clin Chim Acta 27 112 (1981) 67-75
2. *10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res 55 (1995) 5226-5229
3. Vatsis K.P., Weber W.W., Bell D.A., et al. Nomenclature for N-acetyltransferases. Pharmacogenetics 5 (1995) 1-17
4. Coroneos E., and Sim E. Arylamine N-acetyltransferase activity in human cultured cell lines. Biochem Soc Trans 19 (1991) 129
5. Badawi A.F., Hirvonen A., Bell D.A., Lang N.P., and Kadlubar F.F. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res 55 (1995) 5230-5237
6. Bruhn C., Brockmoller J., Cascorbi I., Roots I., and Borchert H.H. Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1). Biochem Pharmacol 58 (1999) 1759-1764
7. Sekine A., Saito S., Iida A., et al. Identification of single-nucleotide polymorphisms (SNPs) of human N-acetyltransferase genes NAT1, NAT2, AANAT, ARD1 and L1CAM in the Japanese population. J Hum Genet 46 (2001) 314-319
8. Zhao B., Lee E.J., Yeoh P.N., and Gong N.H. Detection of mutations and polymorphism of N-acetyltransferase 1 gene in Indian, Malay and Chinese populations. Pharmacogenetics 8 (1998) 299-304
9. Paryton M.A., and Sim E. Genotyping human arylamine N-acetyltransferse type 1 (NAT1). Biochem Pharmacol 55 (1998) 361-366
10. Hughes N.C., Janezic S.A., McQueen K.L., et al. Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as in vivo and in vitro probe. Pharmacogenetics 8 (1998) 55-66
11. Risch A., Smelt V., Lane D., et al. Arylamine N-acetyltransferase in erythrocytes of cystic fibrosis patients. Pharmacol Toxicol 78 (1996) 235-240
12. Caribb A.E., Grant D.M., Miller M.A., et al. Expression of monomorphic arylamine N-acetyltransferse (NAT1) in human leukocytes. J Pharmacol Exp Ther 259 (1991) 1241-1246
13. Bell D.A., Stephens E.A., Castranio T., et al. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res 55 (1995) 3537-3542
14. Meisler M.H., and Reinke C. A sensitive fluorescent assay for N-acetyltransferase activity in human lymphocytes from newborns and adults. Clin Chim Acta 96 1-2 (1979 (Aug. 15)) 91-96
15. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
16. Kukongviriyapan V., Prawan A., Warasiha B., et al. Polymorphism of N-acetyltransferase 1 and correlation between genotype and phenotype in a Thai population. Eur J Clin Pharmacol 59 (2003) 277-281
17. *) using polymerase chain reaction-restriction fragment-single strand conformation polymorphism assay. Pharmacogenetics 10 (2000) 293-300
18. Loktionov A., Moore W., Spencer S.P., et al. Differences in N-acetylation genotypes between Caucasians and Black South Africans: implications for cancer prevention. Cancer Detect Prev 26 (2002) 15-22
19. Zheng W., Deitz A.C., Campbell D.R., et al. N-Acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 8 (1999) 233-239
20. Vineis P. Epidemiology of cancer from exposure to arylamines. Environ Health Perspect 106 Suppl. 6 (1994) 7-10
21. 560A mutations. Pharmacogenetics 8 (1998) 67-72
22. Kornbluth A., and Sachar D.B. Ulcerative colitis practice guidelines in adults. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 92 (1997) 204-211
23. Peppercorn M.A., and Goldman P. The role of intestinal bacteria in the metabolism of salicylazosulfapyridine. J Pharmacol Exp Ther 181 (1972) 555-562
24. Allgayer H., Ahnfelt N.O., Kruis W., et al. Colonic N-acetylation of 5-aminosalicylic acid in inflammatory bowel disease. Gastroenterology 97 (1989) 38-41
25. Hein D.W., Doll M.A., Rustan T.D., et al. Metabolic activation and deactivation of aryalmine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogen 14 (1993) 1633-1638
26. Zenser R.B., Lakshmi V.M., Rustan T.R., et al. Human N-acetylation of benzidine: role of NAT1 and NAT2. Cancer Res 56 (1996) 3941-3947
27. De Leon J.H., Vatsis K.P., and Weber W.W. Characterization of naturally occurring and recombinant human N-acetyltransferase variants encoded by NAT1. Mol Pharmacol 58 (2000) 288-299
28. Fretland A.J., Doll M.A., Zhu Y., Smith L., Leff M.A., and Hein D.W. Effect of nucleotide substitutions in N-acetyltransferase-1 on N-acetylation (deactivation) and O-acetylation (activation) of arylamine carcinogens: implications for cancer predisposition. Cancer Detect Prev 26 (2002) 10-14